This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board approves September quarter unaudited results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved unaudited financial results for the quarter ended 30 September 2026, along with the statement of assets and liabilities, cash flow statement and the statutory auditor's limited review report. The filing provides no financial figures, so performance and cash flow trends cannot be assessed.
Results were approved, but no figures are provided to assess earnings, margins, liquidity or the likely stock price impact.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹12.81 Cr | ₹6.01 Cr | +112.9% |
| Operating profit | ₹1.06 Cr | −₹0.75 Cr | turned positive |
| Profit after tax | ₹0.93 Cr | −₹0.57 Cr | turned positive |
| EBITDA margin | 11.7% | -5.4% | +17.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.